US6716991B1
(en)
*
|
1993-11-30 |
2004-04-06 |
G. D. Searle & Co. |
Process for preparing a substituted pyrazolyl benzenesulfonamide for the treatment of inflammation
|
US5466823A
(en)
*
|
1993-11-30 |
1995-11-14 |
G.D. Searle & Co. |
Substituted pyrazolyl benzenesulfonamides
|
US6492411B1
(en)
|
1993-11-30 |
2002-12-10 |
G. D. Searle & Co. |
Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
|
AU3815495A
(en)
*
|
1994-11-08 |
1996-05-31 |
Eisai Co. Ltd. |
Pyrazole derivatives exhibiting anti-inflammatory and analgesic effects
|
US6429221B1
(en)
*
|
1994-12-30 |
2002-08-06 |
Celgene Corporation |
Substituted imides
|
RU2169143C2
(ru)
*
|
1995-05-25 |
2001-06-20 |
Джи. Ди. Сирл Энд Ко. |
Способ получения 3-галогеналкил-1н-пиразолов
|
CA2223154A1
(en)
|
1995-06-02 |
1996-12-05 |
G.D. Searle & Co. |
Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
|
EP0833622B8
(de)
*
|
1995-06-12 |
2005-10-12 |
G.D. Searle & Co. |
Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor
|
US6342510B1
(en)
*
|
1995-06-12 |
2002-01-29 |
G. D. Searle & Co. |
Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitors and a leukotriene B4 receptor antagonist
|
US5700816A
(en)
*
|
1995-06-12 |
1997-12-23 |
Isakson; Peter C. |
Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor
|
US6593361B2
(en)
|
1995-07-19 |
2003-07-15 |
Merck & Co Inc |
Method of treating colonic adenomas
|
US5968974A
(en)
|
1995-07-19 |
1999-10-19 |
Merck & Co., Inc. |
Method of treating colonic adenomas
|
US5756529A
(en)
*
|
1995-09-29 |
1998-05-26 |
G.D. Searle & Co. |
Substituted pyrazolyl benzenesulfonamides for use in veterinary therapies
|
GB9520584D0
(en)
*
|
1995-10-09 |
1995-12-13 |
Fujisawa Pharmaceutical Co |
Pyrazole derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
|
EP0859642A2
(de)
*
|
1995-10-17 |
1998-08-26 |
G.D. Searle & Co. |
Verfahren zur detektion von zyklooxygenase-2
|
JP2000505445A
(ja)
|
1996-02-13 |
2000-05-09 |
ジー.ディー.サール アンド カンパニー |
シクロオキシゲナーゼ―2インヒビターとロイコトリエンb▲下4▼受容体アンタゴニストの投与の免疫抑制作用
|
EP0880363B1
(de)
|
1996-02-13 |
2002-09-11 |
G.D. SEARLE & CO. |
Arzneimittelkombinationen mit immunosuppressiven wirkungen welche cyclooxygenase-2 inhibitoren und leukotrien lta4 hydrase-inhibitoren enthalten
|
WO1997029776A1
(en)
|
1996-02-13 |
1997-08-21 |
G.D. Searle & Co. |
Combinations having immunosuppressive effects, containing cyclooxygenase-2-inhibitors and 5-lipoxygenase inhibitors
|
US5908858A
(en)
*
|
1996-04-05 |
1999-06-01 |
Sankyo Company, Limited |
1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses
|
EE03685B1
(et)
*
|
1996-04-12 |
2002-04-15 |
G.D. Searle & Co. |
Asendatud benseensulfoonamiidi derivaadid kui COX-2 inhibiitorite eelravimid
|
US5677318A
(en)
*
|
1996-07-11 |
1997-10-14 |
Merck Frosst Canada, Inc. |
Diphenyl-1,2-3-thiadiazoles as anti-inflammatory agents
|
RU2239429C2
(ru)
*
|
1996-10-15 |
2004-11-10 |
Джи. Ди. Сирл Энд Ко. |
Способ применения ингибиторов циклооксигеназы-2 для лечения и профилактики неоплазии
|
IT1287174B1
(it)
*
|
1996-11-15 |
1998-08-04 |
Angelini Ricerche Spa |
Diaril-ciclometilenpirazoli farmacologicamente attivi,procedimento per prepararli e composizioni farmaceutiche che li contengono
|
KR20000053362A
(ko)
*
|
1996-11-19 |
2000-08-25 |
윌리암스 로저 에이 |
항 맥관형성제로서 시클로옥시게나제-2 저해제의 이용 방법
|
AU725697B2
(en)
*
|
1997-04-03 |
2000-10-19 |
G.D. Searle & Co. |
Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of dementia
|
WO1998047509A1
(en)
*
|
1997-04-18 |
1998-10-29 |
G.D. Searle & Co. |
Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders
|
US20040072889A1
(en)
*
|
1997-04-21 |
2004-04-15 |
Pharmacia Corporation |
Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia
|
AUPO941497A0
(en)
*
|
1997-09-24 |
1997-10-16 |
Fujisawa Pharmaceutical Co., Ltd. |
Novel compounds
|
AU750356B2
(en)
*
|
1997-09-24 |
2002-07-18 |
Fujisawa Pharmaceutical Co., Ltd. |
1,5-diphenylpyrazole derivatives
|
FR2769311B1
(fr)
*
|
1997-10-07 |
1999-12-24 |
Union Pharma Scient Appl |
Nouveaux derives 3,4-diarylthiazolin-2-one ou -2-thione, leurs procedes de preparation et leurs utilisations en therapeutique
|
US5972986A
(en)
*
|
1997-10-14 |
1999-10-26 |
G.D. Searle & Co. |
Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
|
AUPP042397A0
(en)
*
|
1997-11-18 |
1997-12-11 |
Fujisawa Pharmaceutical Co., Ltd. |
5-arylpyrazole compounds
|
US6025353A
(en)
*
|
1997-11-19 |
2000-02-15 |
G.D. Searle & Co. |
Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents
|
US6887893B1
(en)
|
1997-12-24 |
2005-05-03 |
Sankyo Company, Limited |
Methods and compositions for treatment and prevention of tumors, tumor-related disorders and cachexia
|
AU3387999A
(en)
*
|
1998-04-08 |
1999-10-25 |
Abbott Laboratories |
Pyrazole inhibitors of cytokine production
|
US6294558B1
(en)
|
1999-05-31 |
2001-09-25 |
Pfizer Inc. |
Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
|
US6727238B2
(en)
|
1998-06-11 |
2004-04-27 |
Pfizer Inc. |
Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
|
USRE39708E1
(en)
|
1998-08-07 |
2007-06-26 |
Chiron Corporation |
Estrogen receptor modulators
|
ES2234324T3
(es)
*
|
1998-11-02 |
2005-06-16 |
MERCK & CO., INC. |
Combinaciones de un agonista 5ht1b/1d y un inhibidor selectivo de cox-2 para el tratamiento de la migraña.
|
SA99191255B1
(ar)
|
1998-11-30 |
2006-11-25 |
جي دي سيرل اند كو |
مركبات سيليكوكسيب celecoxib
|
US6858598B1
(en)
|
1998-12-23 |
2005-02-22 |
G. D. Searle & Co. |
Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
US6649645B1
(en)
|
1998-12-23 |
2003-11-18 |
Pharmacia Corporation |
Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia
|
US20040122011A1
(en)
*
|
1998-12-23 |
2004-06-24 |
Pharmacia Corporation |
Method of using a COX-2 inhibitor and a TACE inhibitors as a combination therapy
|
US6833373B1
(en)
|
1998-12-23 |
2004-12-21 |
G.D. Searle & Co. |
Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
US20010024664A1
(en)
*
|
1999-03-19 |
2001-09-27 |
Obukowicz Mark G. |
Selective COX-2 inhibition from edible plant extracts
|
WO2000066562A1
(en)
*
|
1999-05-03 |
2000-11-09 |
Dr. Reddy's Research Foundation |
Pyrazoles having antiinflammatory activity
|
IL136025A0
(en)
*
|
1999-05-14 |
2001-05-20 |
Pfizer Prod Inc |
Combination therapy for the treatment of migraine
|
US6573290B1
(en)
*
|
1999-05-17 |
2003-06-03 |
Ilex Oncology, Inc. |
DFMO and celecoxib in combination for cancer chemoprevention and therapy
|
CO5190664A1
(es)
|
1999-06-30 |
2002-08-29 |
Pfizer Prod Inc |
Terapia de combinacion para el tratamiento de migrana administracion de un receptor 5ht, cafeina y un inhibidor de ciclooxigenasa-2
|
EP1104760B1
(de)
|
1999-12-03 |
2003-03-12 |
Pfizer Products Inc. |
Sulfamoylheteroarylpyrazolverbindungen zur Verwendung als analgetisches/entzündungshemmendes Mittel
|
EP1104759B1
(de)
|
1999-12-03 |
2003-10-22 |
Pfizer Products Inc. |
Heteroarylphenylpyrazolverbindungen zur Verwendung als analgetisches/entzündungshemmendes Mittel
|
BR0016031A
(pt)
|
1999-12-03 |
2002-07-23 |
Pfizer Prod Inc |
Derivados de heterociclo-alquilsulfonil pirazol como agentes antiinflamatórios/analgésicos
|
ES2200787T3
(es)
|
1999-12-03 |
2004-03-16 |
Pfizer Products Inc. |
Derivados de acetileno como agentes antiinflamatorios/analgesicos.
|
UA74539C2
(en)
*
|
1999-12-08 |
2006-01-16 |
Pharmacia Corp |
Crystalline polymorphous forms of celecoxib (variants), a method for the preparation thereof (variants), a pharmaceutical composition (variants)
|
PT1175214E
(pt)
*
|
1999-12-08 |
2005-04-29 |
Pharmacia Corp |
Composicoes de inibidor de ciclo-oxigenase-2 com um inicio rapido do seu efito terapeutico
|
ES2236011T3
(es)
*
|
1999-12-08 |
2005-07-16 |
Pharmacia Corporation |
Formas cristalinas polimorficas de celecoxib.
|
US6964978B2
(en)
*
|
1999-12-08 |
2005-11-15 |
Pharmacia Corporation |
Solid-state form of celecoxib having enhanced bioavailability
|
CN100486573C
(zh)
|
1999-12-23 |
2009-05-13 |
硝化医药股份有限公司 |
硝基化的和亚硝基化的环加氧酶-2抑制剂、组合物及其用途
|
AU2001244608A1
(en)
*
|
2000-03-31 |
2001-10-15 |
Takeda Chemical Industries Ltd. |
Fused heterocyclic derivatives, their production and use
|
JP2003531202A
(ja)
*
|
2000-04-25 |
2003-10-21 |
ファルマシア・コーポレーション |
3,4−ジ(カルボシクリルまたはヘテロシクリル)チオフェンの位置選択的合成
|
US6403629B2
(en)
*
|
2000-05-02 |
2002-06-11 |
J.B. Chemical And Pharmaceuticals Limited |
Heterocyclic compounds for therapeutic use
|
MY120279A
(en)
*
|
2000-05-26 |
2005-09-30 |
Pharmacia Corp |
Use of a celecoxib composition for fast pain relief
|
RU2003100874A
(ru)
*
|
2000-06-13 |
2004-06-27 |
Вайс (Us) |
Болеутоляющие и противовоспалительные составы, содержащие ингибиторы циклооксигеназы-2
|
TR200001872A3
(tr)
*
|
2000-06-26 |
2002-01-21 |
Fako Ilaclari A.S |
4-[5-(4-Metilfenil-3-(triflorometil)-1H-pirazol-1-il] benzensulfonamit' in yeni kristal biçimi "Biçim I" ve bu ürünün üretilmesine iliskin yöntem.
|
PE20020146A1
(es)
*
|
2000-07-13 |
2002-03-31 |
Upjohn Co |
Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
|
WO2002005848A2
(en)
*
|
2000-07-13 |
2002-01-24 |
Pharmacia Corporation |
Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders
|
DE60129330T2
(de)
|
2000-07-20 |
2008-04-10 |
Lauras As |
Verwendung von cox-2 inhibitoren als immunostimulantien zur behandlung von hiv oder aids
|
US6716829B2
(en)
|
2000-07-27 |
2004-04-06 |
Pharmacia Corporation |
Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders
|
GB0021494D0
(en)
*
|
2000-09-01 |
2000-10-18 |
Glaxo Group Ltd |
Chemical comkpounds
|
US20030219461A1
(en)
*
|
2000-09-12 |
2003-11-27 |
Britten Nancy J. |
Parenteral combination therapy for infective conditions
|
AU2002229074A1
(en)
*
|
2000-12-15 |
2002-06-24 |
Pharmacia Corporation |
Selective cox-2 inhibition from plant extracts
|
WO2002047707A2
(en)
*
|
2000-12-15 |
2002-06-20 |
Pharmacia Corporation |
Selective cox-2 inhibition from non-edible plant extracts
|
US7115565B2
(en)
*
|
2001-01-18 |
2006-10-03 |
Pharmacia & Upjohn Company |
Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
|
CA2435350A1
(en)
*
|
2001-02-02 |
2002-08-15 |
Pharmacia Corporation |
Method of using a cyclooxygenase-2 inhibitor and sex steroids as a combination therapy for the treatment and prevention of dismenorrhea
|
ITMI20010733A1
(it)
|
2001-04-05 |
2002-10-05 |
Recordati Chem Pharm |
Uso di inibitori dell'isoenzina cox-2 per il trattamento dell'incontinenza urinaria
|
US20030105141A1
(en)
*
|
2001-04-17 |
2003-06-05 |
Ping Gao |
Finely self-emulsifiable pharmaceutical composition
|
US20030105144A1
(en)
|
2001-04-17 |
2003-06-05 |
Ping Gao |
Stabilized oral pharmaceutical composition
|
US6673818B2
(en)
|
2001-04-20 |
2004-01-06 |
Pharmacia Corporation |
Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
|
GB0112810D0
(en)
*
|
2001-05-25 |
2001-07-18 |
Glaxo Group Ltd |
Pyrimidine derivatives
|
GB0112802D0
(en)
*
|
2001-05-25 |
2001-07-18 |
Glaxo Group Ltd |
Pyrimidine derivatives
|
DE10129320A1
(de)
*
|
2001-06-19 |
2003-04-10 |
Norbert Mueller |
Verwendung von COX-2 Inhibitoren zur Behandlung von Schizophrenie, wahnhaften Störungen, affektiven Störungen oder Ticstörungen
|
US20060167074A1
(en)
*
|
2001-06-19 |
2006-07-27 |
Norbert Muller |
Methods and compositions for the treatment of psychiatric disorders
|
ATE298749T1
(de)
|
2001-07-05 |
2005-07-15 |
Pfizer Prod Inc |
Heterocyclo-alkylsulfonyl pyrazole als entzündungshemmende/analgetische mittel
|
DE10135027A1
(de)
*
|
2001-07-18 |
2003-02-06 |
Solvay Pharm Gmbh |
Verwendung Trifluoracetylalkyl-substituierter Phenyl-, Phenol- und Benzoylderivate in der Behandlung und/oder Prophylaxe von Obestias und deren Begleit- und/oder Folgeerkrankungen
|
UA80682C2
(en)
*
|
2001-08-06 |
2007-10-25 |
Pharmacia Corp |
Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition
|
GB0119477D0
(en)
*
|
2001-08-09 |
2001-10-03 |
Glaxo Group Ltd |
Pyrimidine derivatives
|
US20040067992A1
(en)
*
|
2001-08-10 |
2004-04-08 |
Pharmacia Corporation |
Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia
|
US20030220376A1
(en)
*
|
2001-08-10 |
2003-11-27 |
Pharmacia Corporation |
Methods for treating carbonic anhydrase mediated disorders
|
US20030100594A1
(en)
*
|
2001-08-10 |
2003-05-29 |
Pharmacia Corporation |
Carbonic anhydrase inhibitor
|
CA2456939A1
(en)
*
|
2001-08-10 |
2003-02-20 |
Pharmacia Corporation |
Carbonic anhydrase inhibitors
|
US20030114418A1
(en)
*
|
2001-08-14 |
2003-06-19 |
Pharmacia Corporation |
Method for the treatment and prevention of pain and inflammation with glucosamine and a cyclooxygenase-2 selective inhibitor and compositions therefor
|
US20030114416A1
(en)
*
|
2001-08-14 |
2003-06-19 |
Pharmacia Corporation |
Method and compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate
|
US20050101563A1
(en)
*
|
2001-08-14 |
2005-05-12 |
Pharmacia Corporation |
Method and compositions for the treatment and prevention of pain and inflammation
|
AR038957A1
(es)
|
2001-08-15 |
2005-02-02 |
Pharmacia Corp |
Terapia de combinacion para el tratamiento del cancer
|
BR0212611A
(pt)
*
|
2001-09-19 |
2004-08-17 |
Pharmacia Corp |
Compostos de pirazolila substituìdos para o tratamento da inflamação
|
HN2002000266A
(es)
*
|
2001-09-24 |
2003-11-16 |
Bayer Corp |
Preparacion y uso de derivados de imidazol para el tratamiento de la obesidad.
|
GT200200183A
(es)
|
2001-09-28 |
2003-05-23 |
|
Procedimiento para preparar derivados de heterocicloalquilsulfonil pirazol
|
WO2003037336A1
(en)
|
2001-11-02 |
2003-05-08 |
Pfizer Products Inc. |
1-(5-sulfonyl-pyridin-2-yl)-5-(methylidene-cycloalkylmethoxy)-1h-pyrazole-4-carbonitrile derivatives and other compounds as cyclooxygenase inhibitors for the treatment of arthritis, neurodegeneration and colon cancer
|
DE10162121A1
(de)
*
|
2001-12-12 |
2003-06-18 |
Berolina Drug Dev Ab Svedala |
Deuterierte substituierte Pyrazolyl-Benzolsulfonamide sowie diese Verbindungen enthaltende Arzneimittel
|
US20040126438A1
(en)
*
|
2001-12-13 |
2004-07-01 |
Obukowicz Mark G. |
Selective cox-2 inhibition from plant extracts
|
US20040062823A1
(en)
*
|
2001-12-13 |
2004-04-01 |
Obukowicz Mark G. |
Selective cox-2 inhibition from non-edible plant extracts
|
US20030212138A1
(en)
*
|
2002-01-14 |
2003-11-13 |
Pharmacia Corporation |
Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor
|
US20030220374A1
(en)
*
|
2002-01-14 |
2003-11-27 |
Pharmacia Corporation |
Compositions and methods of treatment involving peroxisome proliferator-activated receptor-gamma agonists and cyclooxygenase-2 selective inhibitors
|
US7927613B2
(en)
*
|
2002-02-15 |
2011-04-19 |
University Of South Florida |
Pharmaceutical co-crystal compositions
|
WO2004026235A2
(en)
*
|
2002-09-20 |
2004-04-01 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical compositions with improved dissolution
|
US20090088443A1
(en)
*
|
2002-02-15 |
2009-04-02 |
Julius Remenar |
Novel crystalline forms of conazoles and methods of making and using the same
|
US7790905B2
(en)
*
|
2002-02-15 |
2010-09-07 |
Mcneil-Ppc, Inc. |
Pharmaceutical propylene glycol solvate compositions
|
US20100311701A1
(en)
*
|
2002-02-15 |
2010-12-09 |
Transform Pharmaceuticals, Inc |
Pharmaceutical Co-Crystal Compositions
|
CA2477923C
(en)
*
|
2002-03-01 |
2021-02-23 |
University Of South Florida |
Multiple-component solid phases containing at least one active pharmaceutical ingredient
|
TW562937B
(en)
*
|
2002-03-26 |
2003-11-21 |
Nanya Technology Corp |
Method for fast determining defect type of word line
|
AU2003230836A1
(en)
*
|
2002-04-08 |
2003-10-27 |
The Ohio State University Research Foundation |
Compounds and methods for inducing apoptosis in proliferating cells
|
US20040034083A1
(en)
*
|
2002-04-18 |
2004-02-19 |
Stephenson Diane T. |
Combination therapy for the treatment of Parkinson's disease with cyclooxygenase-2 (COX2) inhibitor(s)
|
EP1505962A2
(de)
*
|
2002-04-18 |
2005-02-16 |
Pharmacia Corporation |
Monotherapie zur behandlung der parkinson-krankheit mit cyclooxygenase-2 (cox 2) hemmer(n)
|
CA2485298C
(en)
*
|
2002-05-09 |
2008-03-11 |
Pharmacia Corporation |
Substituted pyrazolyl compounds for the treatment of inflammation
|
EP1507766A4
(de)
*
|
2002-05-24 |
2006-06-14 |
Pharmacia Corp |
Synthese von diarylpyrazolen
|
CN100360117C
(zh)
|
2002-06-21 |
2008-01-09 |
转化医药公司 |
具有提高的溶出度的药物组合物
|
JP2006501179A
(ja)
|
2002-06-27 |
2006-01-12 |
ニトロメッド インコーポレーティッド |
シクロオキシゲナーゼ−2選択的阻害剤、組成物、および使用方法
|
WO2004002420A2
(en)
|
2002-06-28 |
2004-01-08 |
Nitromed, Inc. |
Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use
|
KR100467668B1
(ko)
*
|
2002-08-07 |
2005-01-24 |
씨제이 주식회사 |
1,2,4-트리아졸 유도체, 그 제조방법 및 약제학적 조성물
|
US7235560B2
(en)
*
|
2002-08-19 |
2007-06-26 |
Glaxo Group Limited |
Pyrimidine derivative as selective COX-2 inhibitors
|
GB0221443D0
(en)
|
2002-09-16 |
2002-10-23 |
Glaxo Group Ltd |
Pyridine derivates
|
US20040087558A1
(en)
*
|
2002-10-24 |
2004-05-06 |
Zeldis Jerome B. |
Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain
|
US20050203142A1
(en)
*
|
2002-10-24 |
2005-09-15 |
Zeldis Jerome B. |
Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain
|
GB0227443D0
(en)
*
|
2002-11-25 |
2002-12-31 |
Glaxo Group Ltd |
Pyrimidine derivatives
|
US20060148877A1
(en)
*
|
2002-11-26 |
2006-07-06 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical formulations of celcoxib
|
KR20070091049A
(ko)
|
2002-12-13 |
2007-09-06 |
워너-램버트 캄파니 엘엘씨 |
하부요로증상을 치료하기 위한 알파-2-델타 리간드
|
US20040204411A1
(en)
*
|
2002-12-17 |
2004-10-14 |
Pharmacia Corporation |
Method for the treatment, prevention, or inhibition of a CNS disorder and/or pain and inflammation using a combination of reboxetine and a cyclooxygenase-2 selective inhibitor and compositions thereof
|
US20040235925A1
(en)
*
|
2002-12-17 |
2004-11-25 |
Pharmacia Corporation |
Method for the treatment, prevention, or inhibition of a CNS disorder and/or pain and inflammation using a combination of duloxetine, venlafaxine or atomoxetine and a cyclooxygenase-2 selective inhibitor and compositions thereof
|
US20080153894A1
(en)
*
|
2002-12-19 |
2008-06-26 |
Pharmacia Corporation |
Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis
|
ES2215474B1
(es)
|
2002-12-24 |
2005-12-16 |
J. URIACH & CIA S.A. |
Nuevos derivados de fosforamida.
|
EP2339328A3
(de)
|
2002-12-30 |
2011-07-13 |
Transform Pharmaceuticals, Inc. |
Pharmazeutische kokristallisierte Celecoxib-Zusammensetzungen
|
US8183290B2
(en)
*
|
2002-12-30 |
2012-05-22 |
Mcneil-Ppc, Inc. |
Pharmaceutically acceptable propylene glycol solvate of naproxen
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
CA2552137A1
(en)
*
|
2003-01-29 |
2004-08-19 |
Children's Medical Center Corporation |
Prevention of surgical adhesions using selective cox-2 inhibitors
|
US20040220155A1
(en)
*
|
2003-03-28 |
2004-11-04 |
Pharmacia Corporation |
Method of providing a steroid-sparing benefit with a cyclooxygenase-2 inhibitor and compositions therewith
|
US20060142368A1
(en)
*
|
2003-04-08 |
2006-06-29 |
Ching-Shih Chen |
Compounds and methods for inducing apoptosis in proliferating cells
|
CA2524610C
(en)
*
|
2003-05-07 |
2014-03-25 |
Osteologix A/S |
Strontium combinations for prophylaxis/treatment of cartilage and/or bone conditions
|
DK1534305T3
(da)
|
2003-05-07 |
2007-02-05 |
Osteologix As |
Behandling af brusk-/knoglelidelser med vandoplöselige strontiumsalte
|
CN1309717C
(zh)
*
|
2003-06-03 |
2007-04-11 |
李小虎 |
4-芳基-5h-噻吩-2-酮衍生物、其制法和用途
|
GB0319037D0
(en)
*
|
2003-08-13 |
2003-09-17 |
Glaxo Group Ltd |
7-Azaindole Derivatives
|
US20050119262A1
(en)
*
|
2003-08-21 |
2005-06-02 |
Pharmacia Corporation |
Method for preventing or treating an optic neuropathy with a cox-2 inhibitor and an intraocular pressure reducing agent
|
US20050107350A1
(en)
*
|
2003-08-22 |
2005-05-19 |
Pharmacia Corporation |
Method for the treatment or prevention of bone disorders with a cyclooxygenase-2 inhibitor alone and in combination with a bone disorder treatment agent and compositions therewith
|
US20050131028A1
(en)
*
|
2003-09-11 |
2005-06-16 |
Pharmacia Corporation |
Methods and compositions for the extended duration treatment of pain, inflammation and inflammation-related disorders
|
WO2005044130A1
(en)
*
|
2003-10-03 |
2005-05-19 |
The Ohio State University Research Foundation |
Pdk-1/akt signaling inhibitors
|
US20060079566A1
(en)
*
|
2003-10-03 |
2006-04-13 |
Ching-Shih Chen |
PDK-1/Akt signaling inhibitors
|
US20060014813A1
(en)
*
|
2003-11-26 |
2006-01-19 |
Patrick Connelly |
Pharmaceutical compounds that regenerate in vivo
|
WO2005054181A1
(ja)
*
|
2003-12-01 |
2005-06-16 |
Reverse Proteomics Research Institute Co., Ltd. |
抗癌剤の新規標的タンパク質および対応する新規抗癌剤(スプナール)
|
US7067159B2
(en)
|
2003-12-05 |
2006-06-27 |
New Chapter, Inc. |
Methods for treating prostate cancer with herbal compositions
|
US7070816B2
(en)
|
2003-12-05 |
2006-07-04 |
New Chapter, Inc. |
Methods for treating prostatic intraepithelial neoplasia with herbal compositions
|
TW200526641A
(en)
*
|
2003-12-26 |
2005-08-16 |
Daiichi Seiyaku Co |
Amidopyrazole derivatives
|
US7927821B2
(en)
*
|
2004-04-12 |
2011-04-19 |
Takeda Pharmaceutical Company Limited |
Methods of screening for compounds which bind G protein-coupled receptors
|
ITMI20041032A1
(it)
|
2004-05-24 |
2004-08-24 |
Neuroscienze S C A R L |
Compositi farmaceutici
|
WO2006041855A2
(en)
|
2004-10-04 |
2006-04-20 |
Nitromed, Inc. |
Compositions and methods using apocynin compounds and nitric oxide donors
|
EP1811992A2
(de)
*
|
2004-10-28 |
2007-08-01 |
Celgene Corporation |
Verfahren und zusammensetzungen unter verwendung von pde4-modulatoren zur behandlung und versorgung von verletzungen des zentralen nervensystems
|
CA2589167A1
(en)
|
2004-11-23 |
2006-06-01 |
Pliva Hrvatska D.O.O. |
Extended release pharmaceutical composition of celecoxib
|
ES2552338T3
(es)
|
2005-01-21 |
2015-11-27 |
Astex Therapeutics Limited |
Compuestos farmacéuticos
|
US7521435B2
(en)
|
2005-02-18 |
2009-04-21 |
Pharma Diagnostics, N.V. |
Silicon containing compounds having selective COX-2 inhibitory activity and methods of making and using the same
|
US7923465B2
(en)
|
2005-06-02 |
2011-04-12 |
Glenmark Pharmaceuticals S.A. |
Cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation
|
US20080200527A1
(en)
*
|
2005-06-17 |
2008-08-21 |
Carex Sa |
Cannabinoid Receptor Modulators
|
MX2008000141A
(es)
*
|
2005-06-27 |
2008-04-07 |
Exelixis Inc |
Moduladores de lxr basados en imidazol.
|
HUP0500730A2
(en)
*
|
2005-07-29 |
2007-02-28 |
Richter Gedeon Vegyuszeti Gyar |
1,2-diaryl-heterocyclic compounds, their preparation, pharmaceutical compositions comprising thereof and their use
|
WO2007016677A2
(en)
|
2005-08-02 |
2007-02-08 |
Nitromed, Inc. |
Nitric oxide enhancing antimicrobial compounds, compositions and methods of use
|
EP1954685A4
(de)
|
2005-11-16 |
2009-11-11 |
Nitromed Inc |
Furoxanverbindungen, zusammensetzungen und anwendungsverfahren
|
US20070154542A1
(en)
*
|
2005-12-30 |
2007-07-05 |
Cogentus Pharmaceuticals, Inc. |
Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
|
AU2007243765A1
(en)
|
2006-03-29 |
2007-11-08 |
Nicox S.A. |
Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
|
US8128460B2
(en)
*
|
2006-09-14 |
2012-03-06 |
The Material Works, Ltd. |
Method of producing rust inhibitive sheet metal through scale removal with a slurry blasting descaling cell
|
EP2073807A1
(de)
|
2006-10-12 |
2009-07-01 |
Astex Therapeutics Limited |
Pharmazeutische kombinationen
|
US8916552B2
(en)
|
2006-10-12 |
2014-12-23 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
KR20090094125A
(ko)
|
2006-12-08 |
2009-09-03 |
엑셀리시스, 인코포레이티드 |
Lxr 및 fxr 조절자
|
DK2125021T3
(da)
|
2006-12-22 |
2011-09-19 |
Recordati Ireland Ltd |
Kombinationsterapi af sygdomme i de nedre urinveje med alfa2delta-ligander og NSAID'er
|
FR2911136B1
(fr)
*
|
2007-01-05 |
2009-02-20 |
Sanofi Aventis Sa |
Derives de n-(4-cyano-1h-pyrazol-3-yl)methylamine substitues leur preparation et leur application en therapeutique.
|
US20100111858A1
(en)
*
|
2007-01-19 |
2010-05-06 |
Howard Carol P |
Diangostic and Therapeutic Cyclooxygenase-2 Binding Ligands
|
RU2515968C2
(ru)
*
|
2007-04-11 |
2014-05-20 |
Киссеи Фармасьютикал Ко., Лтд. |
5-членное гетероциклическое соединение и его применение для лекарственных целей
|
US8039502B2
(en)
|
2007-07-24 |
2011-10-18 |
The Ohio State University Research Foundation |
Anti-infective agents against intracellular pathogens
|
US20090062364A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched celecoxib
|
EP2305645B1
(de)
|
2008-06-20 |
2012-05-16 |
NHWA Pharma.corporation |
Aralkylpiperidinderivate und ihre verwendungen als schmerz- oder beruhigungsmittel
|
WO2010033941A1
(en)
|
2008-09-22 |
2010-03-25 |
Array Biopharma Inc. |
Substituted imidazo[1,2b]pyridazine compounds as trk kinase inhibitors
|
EP2177215A1
(de)
|
2008-10-17 |
2010-04-21 |
Laboratorios Del. Dr. Esteve, S.A. |
Co-Kristalle von Tramadol und NSARs
|
US8513263B2
(en)
|
2008-10-22 |
2013-08-20 |
Array Biopharma Inc. |
Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors
|
US8785466B2
(en)
*
|
2008-10-31 |
2014-07-22 |
Loyola University Chicago |
Methods of using proteinacious channels to identify pharmaceutical treatments and risks, and treatments resulting therefrom
|
US8686017B2
(en)
*
|
2008-10-31 |
2014-04-01 |
Loyola University Chicago |
Methods of using proteinacious channels to identify pharmaceutical treatments and risks, and treatments resulting therefrom
|
US20120108823A1
(en)
|
2009-04-22 |
2012-05-03 |
The Ohio State University Research Foundation |
Anti-francisella agents
|
WO2010150144A2
(en)
|
2009-06-25 |
2010-12-29 |
Wockhardt Research Centre |
Low dose pharmaceutical compositions of celecoxib
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
WO2011050944A1
(en)
|
2009-10-28 |
2011-05-05 |
Ratiopharm Gmbh |
Formulations containing celecoxib
|
WO2011055233A2
(en)
|
2009-11-03 |
2011-05-12 |
Actavis Group Ptc Ehf |
Improved process for preparing celecoxib polymorph
|
KR102113960B1
(ko)
|
2010-03-30 |
2020-05-21 |
베르선 코포레이션 |
트롬빈 억제제로서의 다중치환된 방향족 화합물
|
CN102971322B
(zh)
|
2010-05-20 |
2016-02-17 |
阵列生物制药公司 |
作为trk激酶抑制剂的大环化合物
|
EP2635274B1
(de)
|
2010-11-01 |
2017-12-06 |
The Ohio State University Research Foundation |
Celecoxibderivate gegen staphylokokken
|
CN102746231A
(zh)
*
|
2011-04-20 |
2012-10-24 |
天津药物研究院 |
塞来昔布制备工艺
|
AR086745A1
(es)
|
2011-06-27 |
2014-01-22 |
Parion Sciences Inc |
3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
|
RS58514B1
(sr)
|
2012-06-13 |
2019-04-30 |
Incyte Holdings Corp |
Supstituisana triciklična jedinjenja kao inhibitori fgfr
|
EP2861562B1
(de)
*
|
2012-06-14 |
2018-05-09 |
Mayo Foundation For Medical Education And Research |
Pyrazolderivate als hemmer von stat3
|
CN102746232A
(zh)
*
|
2012-07-03 |
2012-10-24 |
石药集团中诺药业(石家庄)有限公司 |
一种塞来昔布杂质的制备方法
|
WO2014012074A2
(en)
*
|
2012-07-12 |
2014-01-16 |
Euclises Pharmaceuticals, Inc. |
No-releasing nonoate (nitrogen-bound) sulfonamide-linked-coxib anti-cancer agents
|
WO2014012000A2
(en)
|
2012-07-12 |
2014-01-16 |
Euclises Pharmaceuticals, Inc. |
No-releasing guanidine-coxib anti-cancer agents
|
US9505765B2
(en)
|
2012-07-26 |
2016-11-29 |
Confluence Life Sciences Inc. |
4-alkoxy/aralkoxy-5-substituted-pyrrolopyrimidine compounds as TAK1 inhibitors in disease treatment
|
LT2938191T
(lt)
|
2012-12-28 |
2018-05-10 |
Dow Agrosciences Llc |
Sinergistiniai fungicidiniai mišiniai, skirti grybelių kontrolei javuose
|
US9107947B2
(en)
|
2013-01-31 |
2015-08-18 |
The Penn State Research Foundation |
Anti-cancer compositions and methods
|
WO2014138616A2
(en)
*
|
2013-03-08 |
2014-09-12 |
Translational Drug Development, Llc |
Pyrazole compounds and methods of use thereof
|
KR20150132148A
(ko)
|
2013-03-15 |
2015-11-25 |
베르선 코포레이션 |
세린 프로타아제 억제제로서의 다중 치환된 방향족 화합물
|
CN110423221A
(zh)
*
|
2013-03-15 |
2019-11-08 |
维颂公司 |
作为凝血酶抑制剂的卤代吡唑
|
AU2014253798C1
(en)
|
2013-04-19 |
2019-02-07 |
Incyte Holdings Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
US9453002B2
(en)
|
2013-08-16 |
2016-09-27 |
Janssen Pharmaceutica Nv |
Substituted imidazoles as N-type calcium channel blockers
|
CN104974091B
(zh)
*
|
2014-04-10 |
2018-01-02 |
沈阳药科大学 |
3‑甲基‑1,5‑二芳基吡唑类化合物及其制备方法和用途
|
CA2960790A1
(en)
|
2014-09-17 |
2016-03-24 |
Verseon Corporation |
Pyrazolyl-substituted pyridone compounds as serine protease inhibitors
|
HRP20230271T1
(hr)
|
2014-11-16 |
2023-06-09 |
Array Biopharma, Inc. |
Kristalni oblik (s)-n-(5-((r)-2-(2,5-difluorofenil)-pirolidin-1-il)-pirazolo[1,5-a]pirimidin-3-il)-3-hidroksipirolidin-1-karboksamid hidrogen sulfata
|
EP3240413B1
(de)
|
2014-12-30 |
2020-05-13 |
Dow Agrosciences LLC |
Picolinamidverbindungen mit fungizider aktivität
|
US10188109B2
(en)
|
2014-12-30 |
2019-01-29 |
Dow Agrosciences Llc |
Picolinamide compounds with fungicidal activity
|
CA2971433A1
(en)
|
2014-12-30 |
2016-07-07 |
Dow Agrosciences Llc |
Picolinamides with fungicidal activity
|
RU2702088C2
(ru)
|
2014-12-30 |
2019-10-03 |
ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи |
Применение соединений пиколинамида в качестве фунгицидов
|
JP2018500361A
(ja)
|
2014-12-30 |
2018-01-11 |
ダウ アグロサイエンシィズ エルエルシー |
殺真菌剤としてのピコリンアミドの使用
|
KR20170103838A
(ko)
|
2015-01-23 |
2017-09-13 |
컨플루언스 라이프 사이언시스, 인코포레이티드 |
염증 및 암의 치료를 위한 헤테로시클릭 itk 저해제
|
ES2751669T3
(es)
|
2015-02-20 |
2020-04-01 |
Incyte Corp |
Heterociclos bicíclicos como inhibidores FGFR
|
MA41551A
(fr)
|
2015-02-20 |
2017-12-26 |
Incyte Corp |
Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
|
AU2016224974B2
(en)
|
2015-02-27 |
2019-09-26 |
Verseon Corporation |
Substituted pyrazole compounds as serine protease inhibitors
|
WO2016177776A1
(en)
|
2015-05-04 |
2016-11-10 |
Academisch Medisch Centrum |
Biomarkers for the detection of aspirin insensitivity
|
CN117547528A
(zh)
|
2015-05-28 |
2024-02-13 |
瑞迪博士实验室有限公司 |
用于治疗疼痛的塞来昔布口服组合物
|
CN104945388A
(zh)
*
|
2015-07-09 |
2015-09-30 |
南京大学 |
4-(3-(3-(4-氯香豆素)-酰腙)-5-苯基-吡唑)苯磺酰胺类衍生物的制备方法及在抗癌药物中的应用
|
RU2744852C2
(ru)
|
2015-10-26 |
2021-03-16 |
Локсо Онколоджи, Инк. |
Точечные мутации в устойчивых к ингибитору trk злокачественных опухолях и связанные с ними способы
|
EP3413889A1
(de)
|
2016-02-10 |
2018-12-19 |
Cocoon Biotech Inc. |
Zusammensetzungen mit seidenfibroin mit benzenesulfonamidhaltigen nichtsteroidalen entzündungshemmenden wirkstoffen und einem geliermittel und verwendungen davon
|
SG11201808559PA
(en)
|
2016-04-04 |
2018-10-30 |
Loxo Oncology Inc |
Liquid formulations of (s)-n-(5-((r)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide
|
US10045991B2
(en)
|
2016-04-04 |
2018-08-14 |
Loxo Oncology, Inc. |
Methods of treating pediatric cancers
|
SI3800189T1
(sl)
|
2016-05-18 |
2023-11-30 |
Loxo Oncology, Inc. |
Priprava (s)-n-(5-((r)-2-(2,5-difluorofenil)pirolidin-1-il)pirazolo (1,5-a)pirimidin-3-il)-3-hidroksipirolidin-1-karboksamida
|
US10722456B2
(en)
|
2016-05-27 |
2020-07-28 |
Dr. Reddy's Laboratories Ltd |
Oral composition of celecoxib for treatment of pain
|
JOP20190092A1
(ar)
|
2016-10-26 |
2019-04-25 |
Array Biopharma Inc |
عملية لتحضير مركبات بيرازولو[1، 5-a]بيريميدين وأملاح منها
|
JOP20190213A1
(ar)
|
2017-03-16 |
2019-09-16 |
Array Biopharma Inc |
مركبات حلقية ضخمة كمثبطات لكيناز ros1
|
TW201842851A
(zh)
|
2017-05-02 |
2018-12-16 |
美商陶氏農業科學公司 |
用於穀類中的真菌防治之協同性混合物
|
TWI774761B
(zh)
|
2017-05-02 |
2022-08-21 |
美商科迪華農業科技有限責任公司 |
用於穀物中的真菌防治之協同性混合物
|
WO2018204438A1
(en)
|
2017-05-02 |
2018-11-08 |
Dow Agrosciences Llc |
Use of an acyclic picolinamide compound as a fungicide for fungal diseases on turfgrasses
|
AR111960A1
(es)
|
2017-05-26 |
2019-09-04 |
Incyte Corp |
Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
|
MX2020004946A
(es)
|
2017-11-03 |
2020-09-25 |
Aclaris Therapeutics Inc |
Inhibidores jak de pirrolopiridina sustituidos y metodos para producir y utilizar los mismos.
|
BR102019004480B1
(pt)
|
2018-03-08 |
2023-03-28 |
Dow Agrosciences Llc |
Picolinamidas como fungicidas
|
BR112020022373A2
(pt)
|
2018-05-04 |
2021-02-02 |
Incyte Corporation |
sais de um inibidor de fgfr
|
EP3788047B1
(de)
|
2018-05-04 |
2024-09-04 |
Incyte Corporation |
Feste formen eines fgfr-inhibitors und verfahren zur herstellung davon
|
KR20210044822A
(ko)
|
2018-08-10 |
2021-04-23 |
어클라리스 쎄라퓨틱스, 인코포레이티드 |
피롤로피리미딘 itk 억제제
|
CN111039982A
(zh)
*
|
2018-10-12 |
2020-04-21 |
南京大学 |
一类含新型磷脂胺骨架的吡唑磺胺衍生物的设计、合成
|
JP2022512697A
(ja)
|
2018-10-15 |
2022-02-07 |
コルテバ アグリサイエンス エルエルシー |
オキシピコリンアミドの合成のための方法
|
WO2020185532A1
(en)
|
2019-03-08 |
2020-09-17 |
Incyte Corporation |
Methods of treating cancer with an fgfr inhibitor
|
BR112021021477A2
(pt)
|
2019-05-02 |
2021-12-21 |
Aclaris Therapeutics Inc |
Composto, composição farmacêutica e método para tratar uma doença mediada por jak em um indivíduo necessitando do mesmo
|
US11591329B2
(en)
|
2019-07-09 |
2023-02-28 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
WO2021076602A1
(en)
|
2019-10-14 |
2021-04-22 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
US11566028B2
(en)
|
2019-10-16 |
2023-01-31 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
CA3163875A1
(en)
|
2019-12-04 |
2021-06-10 |
Incyte Corporation |
Tricyclic heterocycles as fgfr inhibitors
|
BR112022010664A2
(pt)
|
2019-12-04 |
2022-08-16 |
Incyte Corp |
Derivados de um inibidor de fgfr
|
US12012409B2
(en)
|
2020-01-15 |
2024-06-18 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
WO2022149937A2
(ko)
|
2021-01-08 |
2022-07-14 |
서울대학교 산학협력단 |
골관절염 치료를 위한 건조된 세포 분비물 기반 치료제
|
EP4323405A1
(de)
|
2021-04-12 |
2024-02-21 |
Incyte Corporation |
Kombinationstherapie mit einem fgfr-inhibitor und einem auf nectin-4 abzielenden mittel
|
JP2024522189A
(ja)
|
2021-06-09 |
2024-06-11 |
インサイト・コーポレイション |
Fgfr阻害剤としての三環式ヘテロ環
|
CN114292235B
(zh)
*
|
2021-12-29 |
2023-04-14 |
江苏天和制药有限公司 |
一种地拉考昔的制备和提纯方法
|